Reckitt Benckiser to Stop Selling Suboxone Tablets
Reckitt Benckiser Group Plc (RB/) will cease production of the Suboxone opioid-dependency drug in tablet form, a person familiar with the decision said today.
The person, who declined to be named, said an announcement from the company will be made later today.
To contact the reporter on this story: Matthew Boyle in London at firstname.lastname@example.org
To contact the editor responsible for this story: Sara Marley at email@example.com
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.